Reaction Details |
| Report a problem with these data |
Target | Cholecystokinin receptor type A |
---|
Ligand | BDBM50411336 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_439005 (CHEMBL889351) |
---|
Ki | 2512±n/a nM |
---|
Citation | McDonald, IM; Black, JW; Buck, IM; Dunstone, DJ; Griffin, EP; Harper, EA; Hull, RA; Kalindjian, SB; Lilley, EJ; Linney, ID; Pether, MJ; Roberts, SP; Shaxted, ME; Spencer, J; Steel, KI; Sykes, DA; Walker, MK; Watt, GF; Wright, L; Wright, PT; Xun, W Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion. J Med Chem50:3101-12 (2007) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cholecystokinin receptor type A |
---|
Name: | Cholecystokinin receptor type A |
Synonyms: | CCK-A receptor | CCK-AR | CCK1-R | CCKAR | CCKAR_HUMAN | CCKRA | Cholecystokinin receptor | Cholecystokinin receptor type A | Cholecystokinin-1 Receptor |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 47859.34 |
Organism: | Homo sapiens (Human) |
Description: | Stable expression of human CCK-1 receptors in HEK 293 cells. |
Residue: | 428 |
Sequence: | MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNT
LVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYF
MGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYS
NLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGI
KFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNS
SAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSY
TSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSH
MSASVPPQ
|
|
|
BDBM50411336 |
---|
n/a |
---|
Name | BDBM50411336 |
Synonyms: | CHEMBL227330 |
Type | Small organic molecule |
Emp. Form. | C32H38N4O5 |
Mol. Mass. | 558.6679 |
SMILES | OC(=O)CCc1cccc(NC(=O)CN2N=C(C3CCCCC3)c3ccccc3N(CC(=O)C3CCCC3)C2=O)c1 |t:15| |
Structure |
|